GGrantIndex
← Leaderboards

Mario Feldman

Washington University

$13,417,473
Attributed
$13,417,473
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,417,473 · 14

By mechanism

R01$9,310,287 · 4
R21$3,016,954 · 7
R41$1,090,232 · 3

Top collaborators

No co-investigators on record.

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingProteinsPathogenInfectionAcinetobacter BaumanniiBacteriaMulti-Drug ResistanceGram-Negative BacteriaProductionCellsFoundationsFutureMutagenesisMolecularPathogenesisPathway InteractionsGenesAcinetobacterPlasmidsPreventIn VivoMouse ModelAntimicrobialPilum

Grant awards (34)

Biogenesis of outer membrane vesicles in human gut bacteria$733,521
R01 · FY2025 · AI · contact PI
Phenylacetic acid catabolism, a novel stress-response pathway in Acinetobacter baumannii$651,984
R01 · FY2025 · AI · contact PI
Acinetobacter baumannii reservoirs within the host$194,375
R21 · FY2025 · AI · contact PI
Biogenesis of outer membrane vesicles in human gut bacteria$764,640
R01 · FY2024 · AI · contact PI
Phenylacetic acid catabolism, a novel stress-response pathway in Acinetobacter baumannii$681,308
R01 · FY2024 · AI · contact PI
Acinetobacter baumannii reservoirs within the host$233,250
R21 · FY2024 · AI · contact PI
A Novel Type VIII Secretion System in Gram-negative Bacteria$194,375
R21 · FY2024 · AI · contact PI
Phenylacetic acid catabolism, a novel stress-response pathway in Acinetobacter baumannii$671,080
R01 · FY2023 · AI · contact PI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii$668,534
R01 · FY2023 · AI · contact PI
A Novel Type VIII Secretion System in Gram-negative Bacteria$234,001
R21 · FY2023 · AI · contact PI
Biogenesis and functions of outer membrane vesicles in Bacteroidetes$195,626
R21 · FY2023 · AI · contact PI
Identifying niche specific adaptations in Acinetobacter baumannii$195,332
R21 · FY2023 · AI · contact PI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii$668,534
R01 · FY2022 · AI · contact PI
Phenylacetic acid catabolism, a novel stress-response pathway in Acinetobacter baumannii$578,050
R01 · FY2022 · AI · contact PI
Identifying niche specific adaptations in Acinetobacter baumannii$250,255
R21 · FY2022 · AI · contact PI
Biogenesis and functions of outer membrane vesicles in Bacteroidetes$236,250
R21 · FY2022 · AI · contact PI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii$684,284
R01 · FY2021 · AI · contact PI
Outer Membrane Vesicles in Human Gut Bacteria$196,875
R21 · FY2021 · AI · contact PI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii$665,586
R01 · FY2020 · AI · contact PI
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA$381,250
R01 · FY2020 · AI · contact PI
Development of a bioconjugate vaccine against Group B Streptococcus$280,104
R41 · FY2020 · AI · contact PI
Outer Membrane Vesicles in Human Gut Bacteria$236,063
R21 · FY2020 · AI · contact PI
Role of T6SS in plasmid-mediated MDR dissemination in Acinetobacter$196,614
R21 · FY2020 · AI · contact PI
Molecular Insights into the Uropathogenesis of MDR Acinetobacter baumannii$621,666
R01 · FY2019 · AI · contact PI
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA$381,250
R01 · FY2019 · AI · contact PI
Development of a bioconjugate vaccine against Group B Streptococcus$300,000
R41 · FY2019 · AI · contact PI
Role of T6SS in plasmid-mediated MDR dissemination in Acinetobacter$234,563
R21 · FY2019 · AI · contact PI
PEPTIDOGLYCAN MODIFICATION AS AN IMMUNITY MECHANISM AGAINST TYPE 6 SECRETION ATTACK IN ACINETOBACTER$190,625
R21 · FY2019 · AI · contact PI
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA$396,100
R01 · FY2018 · AI · contact PI
Glycoengineering a bioconjugate vaccine against Klebsiella pneumoniae$299,999
R41 · FY2018 · AI · contact PI
PEPTIDOGLYCAN MODIFICATION AS AN IMMUNITY MECHANISM AGAINST TYPE 6 SECRETION ATTACK IN ACINETOBACTER$228,750
R21 · FY2018 · AI · contact PI
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA$381,250
R01 · FY2017 · AI · contact PI
Towards a New Generation of Glycoengineered Pneumococcal Bioconjugate Vaccines$210,129
R41 · FY2017 · AI · contact PI
INVESTIGATING TYPE VI SECRETION IN ACINETOBACTER BAUMANNII AND ITS INTERPLAY WITH ANTIBIOTIC RESISTA$381,250
R01 · FY2016 · AI · contact PI